International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study

• Päätekijät: Fanny Ofek (Tekijä), Dana Barchel (Tekijä), Nofar Perets (Tekijä), Tomer Ziv-Baran (Tekijä), Ahmad Mahajna (Tekijä), Talia Filipovich-Rimon (Tekijä), Osnat Garach-Jehoshua (Tekijä), Maya Berlin (Tekijä), Matitiahu Berkovitch (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Introduction: In patients treated with direct oral anti activated factor X (anti-FXa) anticoagulants such as apixaban and rivaroxaban, there are several emergency and non-emergency conditions in which anticoagulation activity should be measured. The validity of the common global clotting tests, prot...